Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7501419 | 0.82 | KCNH2 (0.44) | KCNH2SLC22A12ADORA2ALMNAP2RX7 | |
| SCHEMBL1349924 | 0.82 | TP53 (0.40) | CYP2D6TSHRCYP2C19HIF1ASLC22A12 | |
| SCHEMBL6159202 | 0.78 | KCNH2 (0.48) | KCNH2SLC22A12ADORA2AP2RX7 | |
| SCHEMBL30970238 | 0.75 | CYP2D6 (0.63) | CYP2D6TSHRCYP2C19HIF1AKCNH2 | |
| SCHEMBL6582037 | 0.74 | BRD4 (0.45) | SLC22A12ADORA2A | |
| SCHEMBL6159828 | 0.73 | HSP90AA1 (0.39) | CYP2D6CYP2C19SLC22A12ADORA2ASMN1; SMN2 | |
| SCHEMBL14610431 | 0.72 | CYP2D6 (0.63) | CYP2D6TSHRCYP2C19HIF1AKCNH2 | |
| SCHEMBL6580164 | 0.70 | ADORA2A (0.48) | SLC22A12ADORA2ASMN1; SMN2P2RX7 | |
| Hydrochloric Acid SCHEMBL5644906 | 0.69 | PTGS2 (0.62) | — | |
| SCHEMBL27963398 | 0.68 | KCNH2 (0.63) | CYP2D6TSHRCYP2C19HIF1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863896-B1 | NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS | AVENTIS PHARMA SA (FR) | 2005-02-09 | — | — | EP | disclosed |
| US-5986103-A | IMIDAZOLE SUBSTITUTED BENZENE AND REDUCTION OF ABNORMAL STIMULATION OF ENDOTHELIN RECEPTORS | HOECHST MARION ROUSSEL (FR) | 1999-11-16 | — | — | US | disclosed |
| EP-0863896-A1 | NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS | HOECHST MARION ROUSSEL (FR) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997017340-A1 | NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS | HOECHST MARION ROUSSEL (FR) | 1997-05-15 | — | — | WO | disclosed |